3'UTR sequence for transgene expression
US12043840B2 · kind B2 · utility
1Cited by
2References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 30, 2021 |
| Grant date | Jul 23, 2024 |
| Priority date | — |
| Expiry date | Oct 18, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A40/146
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This disclosure concerns compositions and methods for promoting transcription of a nucleotide sequence in a plant or plant cell, employing a promoter from a GmCAB2 gene. Some embodiments relate to a promoter or a 5′ UTR from a GmCAB2 gene that functions in plants to promote transcription of operably linked nucleotide sequences. Other embodiments relate to a 3′ UTR or a terminator from a GmCAB2 gene that functions in plants to promote transcription of operably linked nucleotide sequences.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.